Innoviva (INVA) Change in Taxes (2022 - 2026)
Innoviva (INVA) posted Change in Taxes of $1.1 million for Q1 2026, down 60.06% on a QoQ basis from $2.6 million in Q3 2025, and down 55.47% year-over-year from $2.4 million in Q1 2025.
Innoviva (INVA) Change in Taxes (2022 - 2026) Analysis & Trends
Innoviva's Change in Taxes history runs 5 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- Quarterly Change in Taxes fell 55.47% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 million (down 1.09% YoY) and the FY2025 annual result came in at $4.1 million, down 90.21% from the prior year.
- Change in Taxes was $1.1 million for Q1 2026 at Innoviva, down from $2.6 million in the prior quarter.
- Across five years, Change in Taxes topped out at $33.8 million in Q3 2022 and bottomed at -$455000.0 in Q2 2025.
- A 5-year average of $3.9 million and a median of $494000.0 in 2024 frame the typical range for Change in Taxes.
- Peak annual rise in Change in Taxes reached 4748.98% in 2025, while the deepest fall reached 192.11% in 2025.
- Innoviva's Change in Taxes stood at $33.8 million in 2022, then sank by 99.56% to $148000.0 in 2023, then jumped by 1772.3% to $2.8 million in 2024, then decreased by 4.4% to $2.6 million in 2025, then sank by 60.06% to $1.1 million in 2026.
- Business Quant data shows INVA's Change in Taxes at $1.1 million in Q1 2026, $2.6 million in Q3 2025, and -$455000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 1.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.06 Mn |
| Mar 31, 2026 | 1.06 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Jun 30, 2025 | -455,000.00 |
| Jun 30, 2025 | -455,000.00 |
| Mar 31, 2025 | 2.38 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Jun 30, 2024 | 494,000.00 |
| Jun 30, 2024 | 494,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Sep 30, 2023 | 148,000.00 |
| Sep 30, 2023 | 148,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 49,000.00 |
| Mar 31, 2023 | 49,000.00 |